抗体

载脂蛋白e, E2, E3, E4(载脂蛋白E, E2, E3, E4)

A2299-76D

100微升

728美元

单克隆

小鼠

未共轭

2B16

载脂蛋白e, E2, E3, E4(载脂蛋白E, E2, E3, E4)

小鼠

单克隆抗体

抗体

100微升

728美元

2B16

IgG1

Applications: Suitable for use in Western Blot, ELISA, Immunoprecipitation and Immunohistochemistry. Other applications have not been tested. Recommended Dilutions: Western Blot: 1:1000-1:10,000 Immunohistochemistry (Frozen, FFPE): 1:1000-1:10,000 The staining intensity of formalin-fixed paraffin embedded tissues may be significantly improved by the pretreatment of: 1. Formic acid (70%) for 10-30 minutes at RT. 2. HIER (Heat Induced Epitope Retrieval) with buffers such as citrate. Optimal dilutions to be determined by the researcher. Source: Ascites Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Hu

Synthetic peptide spanning the polymorphic aa position 158 of Apo E.

Recognizes human Apo E. Recognizes E2, E3 and E4 isoforms of apolipoprotein E. Does not react with mouse and rabbit.

Purified by Protein A affinity chromatography.

Supplied as a liquid in PBS, pH 7.2. No preservative added.

~1毫克/毫升

Product Type: Mab Isotype: IgG1 Clone No: 2B16 Host: mouse Source: human Concentration: ~1mg/ml Form: Supplied as a liquid in PBS, pH 7.2. No preservative added. Purity: Purified by Protein A affinity chromatography. Immunogen: Synthetic peptide spanning the polymorphic aa position 158 of Apo E. Specificity: Recognizes human Apo E. Recognizes E2, E3 and E4 isoforms of apolipoprotein E. Does not react with mouse and rabbit. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

E免疫组化免疫沉淀免疫印迹

-20°C

1. Norman, R.R., et al., “Apolipoprotein E genotyping in Alzheimer’s Disease”, Ann. N.Y. Acad. Science, 801 (Reviews). 2. Munoz, D.G., et al., (2000), CMAJ, 162(1): 65–72. 3. Tomiyama, T., et al., (1999),Cell Mol. Life Sci., 6(3-4): 268–279. 4. Hagberg, J.M., et al., (2000), Physiol. Genomics, 4(2): 101-–108. 5. Saunders, A.M., (2000), J. Neuropathol. Exp. Neurol., 59(9): 751–758. 6. Golabek, A.A., et al., (2000), Biophys. J. 79(2): 1008–1015. 7. Golabek, A.A., et al., (1996), J. Biol. Chem., 271(18): 10602–10606. 8. Zunarelli, E., et al., (2000), Breast Cancer Res. Treat, 63(3): 193–198. 9. Zunarelli, E., et al., (2000), Clin Neuropathol., 19(1): 1–6.